Abstract
Lung cancer remains the significant cause of deaths in males and females worldwide and many attempts have been made for diagnosis and treatment of lung cancer. Nanotechnology has emerged as a novel strategy to design smart nanostructure weapons to combat lung cancer. Recently, the biogenic gold nanoparticles (AuNPs) have attracted highlighted interest for lung cancer theranostics. The current systematic review served to evaluate the anticancer potential of biologically synthesized AuNPs against lung cancer cells through in vitro studies. We provided valuable information regarding the efficacy of biogenic AuNPs suggesting their potential for next generation of anticancer drugs. The articles were identified through international databases involving Cochrane, Web of Science, PubMed, Scopus, Science Direct, ProQuest, and Embase. Eighteen articles were found eligible to enter into the current study. Our findings represented that although some studies reported nontoxicity of biogenic AuNPs against lung cancer cells, most of the studies reported significant anticancer activity of these nanoparticles (NPs) against lung cancer cells. Although the in vitro studies provided preliminary evidence for lung anticancer potential of biogenic AuNPs, further in vivo investigations are required to confirm the efficacy of these NPs through animal models.
Similar content being viewed by others
References
R. L. Siegel, K. D. Miller, and A. Jemal (2019). CA Cancer J. Clin.69, 7.
E. Teh and E. Belcher (2014). Surgery (Oxford).32, 242.
H. Lemjabbar-Alaoui, O. U. Hassan, Y. W. Yang, and P. Buchanan (2015). Biochim. Biophys. Acta.1856, 189.
F. R. Hirsch, G. V. Scagliotti, J. L. Mulshine, R. Kwon, W. J. Curran Jr., Y. L. Wu, and L. Paz-Ares (2017). Lancet.389, 299.
A. Madni, A. Batool, S. Noreen, I. Maqbool, F. Rehman, P. M. Kashif, N. Tahir, and A. Raza (2017). J. Drug Target.25, 499.
M. Saravanan, T. Asmalash, A. Gebrekidan, D. Gebreegziabiher, T. Araya, H. Hilekiros, H. Barabadi, and K. Ramanathan (2018). Pharm. Nanotechnol.6, 17.
D. A. Bolukbas and S. Meiners (2015). Nanomedicine (Lond).10, 3203.
A. M. Cryer and A. J. Thorley (2019). Pharmacol. Ther.198, 189.
F. Mottaghitalab, M. Farokhi, Y. Fatahi, F. Atyabi, and R. Dinarvand (2019). J Control Release.295, 250.
H. Wang, L. Zheng, C. Peng, R. Guo, M. Shen, X. Shi, and G. Zhang (2011). Biomaterials.32, 2979.
H. Wang, L. Zheng, C. Peng, M. Shen, X. Shi, and G. Zhang (2013). Biomaterials.34, 470.
B. Miri, N. Motakef-Kazemi, S. A. Shojaosadati, and A. Morsali (2018). Iran J. Pharm. Res.17, 1164.
Y. H. Chen, C. Y. Tsai, P. Y. Huang, M. Y. Chang, P. C. Cheng, C. H. Chou, D. H. Chen, C. R. Wang, A. L. Shiau, and C. L. Wu (2007). Mol. Pharm.4, 713.
H. W. Kao, Y. Y. Lin, C. C. Chen, K. H. Chi, D. C. Tien, C. C. Hsia, W. J. Lin, F. D. Chen, M. H. Lin, and H. E. Wang (2014). Nanotechnology25, 295102.
H. Barabadi, F. Kobarfard, and H. Vahidi (2018). Iran J. Pharm. Res.17, 87.
M. M. Or Rashid, M. S. Islam, M. A. Haque, M. A. Rahman, M. T. Hossain, and M. A. Hamid (2016). Iran J. Pharm. Res.15, 591.
N. Karimi, A. Chardoli, and A. Fattahi (2017). Iran J. Pharm. Res.16, 1167.
Z. Rezvani Amin, Z. Khashyarmanesh, B. S. Fazly Bazzaz, and Z. Sabeti Noghabi (2019). Iran J. Pharm. Res.18, 210.
M. Maham and R. Karami-Osboo (2017). Iran J Pharm Res.16, 462.
Q. Abbas, M. Saleem, A. R. Phull, M. Rafiq, M. Hassan, K.-H. Lee, and S.-Y. Seo (2017). Iran J. Pharm. Res.16, 760.
S. Salari, S. Esmaeilzadeh Bahabadi, A. Samzadeh-Kermani, and F. Yousefzaei (2019). Iran J. Pharm. Res.18, 430.
T. Ramezani, M. Nabiuni, J. Baharara, K. Parivar, and F. Namvar (2019). Iran J. Pharm. Res.18, 222.
R. Dobrucka (2017). Iran J. Pharm. Res.16, 753.
L. Castro, M. L. Blazquez, J. A. Munoz, F. Gonzalez, and A. Ballester (2013). IET Nanobiotechnol.7, 109.
M. Akter, M. T. Sikder, M. M. Rahman, A. K. M. A. Ullah, K. F. B. Hossain, S. Banik, T. Hosokawa, T. Saito, and M. Kurasaki (2018). J. Adv. Res.9, 1.
N. A. Hanan, H. I. Chiu, M. R. Ramachandran, W. H. Tung, N. N. MohamadZain, N. Yahaya, and V. Lim (2018). Int. J. Mol. Sci.19, E1725.
R. Vijayan, S. Joseph, and B. Mathew (2019). Bioproc Biosyst Eng.42, 305.
R. Vijayan, S. Joseph, and B. Mathew (2018). Artif. Cells Nanomed. Biotechnol.46, 861.
D. Latha, P. Prabu, C. Arulvasu, R. Manikandan, S. Sampurnam, and V. Narayanan (2018). Asian Pac. J. Trop. Biomed.8, 540.
P. Balashanmugam, K. Mosachristas, and E. Kowsalya (2018). Int. J. App. Pharm.10, 153.
P. Singh, H. Singh, S. Ahn, V. Castro-Aceituno, Z. Jimenez, S. Y. Simu, Y. J. Kim, and D. C. Yang (2017). Artif. Cells Nanomed. Biotechnol.45, 1415.
V. Castro-Aceituno, R. Abbai, S. S. Moon, S. Ahn, R. Mathiyalagan, Y. J. Kim, Y. J. Kim, and D. C. Yang (2017). Biomed. Pharmacother.93, 995.
C. Wang, R. Mathiyalagan, Y. J. Kim, V. Castro-Aceituno, P. Singh, S. Ahn, D. Wang, and D. C. Yang (2016). Int. J. Nanomed.11, 3691.
M. Anandan and H. G. Prabu (2018). J. Inorg. Organomet. Polym. Mater.28, 932.
R. Bhat, V. G. Sharanabasava, R. Deshpande, U. Shetti, G. Sanjeev, and A. Venkataraman (2013). J. Photochem. Photobiol. B.125, 63.
P. R. Devi, C. S. Kumar, P. Selvamani, N. Subramanian, and K. Ruckmani (2015). Mater Lett.139, 241.
Y. Y. Foo, V. Periasamy, L. V. Kiew, G. G. Kumar, and N. Abd Malek (2017). Nanomaterials.7, 123.
B. Kumar, K. Smita, L. Cumbal, J. Camacho, E. Hernandez-Gallegos, M. Guadalupe, M. Grijalva, and K. Andrade (2016). Mater Sci. Eng. C Mater. Biol. Appl.62, 725.
S. Manju, B. Malaikozhundan, S. Vijayakumar, S. Shanthi, A. Jaishabanu, P. Ekambaram, and B. Vaseeharan (2016). Microb Pathog.91, 129.
A. Parveen and S. Rao (2015). J. Clust. Sci.26, 775.
S. Rajeshkumar (2016). J. Genet. Eng. Biotechnol.14, 195.
V. Ramalingam, S. Revathidevi, T. Shanmuganayagam, L. Muthulakshmi, and R. Rajaram (2016). RSC Adv.6, 20598.
M. Sathishkumar, S. Pavagadhi, A. Mahadevan, and R. Balasubramanian (2015). Ecotoxicol. Environ. Saf.114, 232.
N. Yang, L. Weihong, and L. Hao (2014). Mater Lett.134, 67.
H. Barabadi, M. A. Mahjoub, B. Tajani, A. Ahmadi, Y. Junejo, and M. Saravanan (2019). J. Clust. Sci.30, 259.
P. Boomi, G. P. Poorani, S. Palanisamy, S. Selvam, G. Ramanathan, S. Ravikumar, H. Barabadi, H. G. Prabu, J. Jeyakanthan, and M. Saravanan (2019). J. Clust. Sci.30, 715.
H. Barabadi, K. Damavandi Kamali, F. Jazayeri Shoushtari, B. Tajani, M. A. Mahjoub, A. Alizadeh, and M. Saravanan (2019). J. Clust. Sci. https://doi.org/10.1007/s10876-019-01588-7.
H. Barabadi, O. Hosseini, K. Damavandi Kamali, F. Jazayeri Shoushtari, M. Rashedi, H. Haghi-Aminjan, and M. Saravanan (2019). J. Clust. Sci. https://doi.org/10.1007/s10876-019-01639-z.
Acknowledgements
This work was financially supported by Shahid Beheshti University of Medical Sciences, Tehran, Iran (Grant Number 18753).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no conflict of interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Barabadi, H., Vahidi, H., Damavandi Kamali, K. et al. Emerging Theranostic Gold Nanomaterials to Combat Lung Cancer: A Systematic Review. J Clust Sci 31, 323–330 (2020). https://doi.org/10.1007/s10876-019-01650-4
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10876-019-01650-4